| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/13/2002 | EP1179065A2 Full-length molecules expressed in human tissues |
| 02/13/2002 | EP1179064A2 Secreted polypeptides and corresponding polynucleotides |
| 02/13/2002 | EP1179063A2 Genes expressed in hippocampus |
| 02/13/2002 | EP1179062A2 Nucleic acids and proteins with p53 activity and altered tetramerization domains |
| 02/13/2002 | EP1179054A2 Use of recombinant parainfluenza viruses (pivs) as vectors to protect against infection and disease caused by piv and other human pathogens |
| 02/13/2002 | EP1179019A2 Immunogenic peptides derived from mage and the use thereof |
| 02/13/2002 | EP1179016A1 Parasite antigens |
| 02/13/2002 | EP1179013A1 Protein scaffold and its use to multimerise monomeric polypeptides |
| 02/13/2002 | EP1179002A1 Methods using mechanisms of action of aroa |
| 02/13/2002 | EP1179000A2 Secreted proteins and uses thereof |
| 02/13/2002 | EP1178983A1 Indole-type derivatives as inhibitors of p38 kinase |
| 02/13/2002 | EP1178836A2 Use of chimeric mutational vectors to change endogenous sequences in solid tissues |
| 02/13/2002 | EP1178829A1 Human monoclonal antibody |
| 02/13/2002 | EP1178828A1 Death domain containing receptor 4 |
| 02/13/2002 | EP1178826A1 Immunotherapy of b-cell malignancies using anti-cd22 antibodies |
| 02/13/2002 | EP1178825A2 Adjuvant combination formulations |
| 02/13/2002 | EP1178824A2 Staphylococcus aureus antigen-containing whole cell vaccine |
| 02/13/2002 | EP1178823A2 New vaccine formulations - 1 |
| 02/13/2002 | EP1178822A2 New vaccine formulations - 2 |
| 02/13/2002 | EP1178821A1 Use of heparin-binding antagonists in the inhibition of bradykinin release |
| 02/13/2002 | EP1178817A2 Molecular interactions in haematopoietic cells |
| 02/13/2002 | EP1178815A1 Death domain containing receptors |
| 02/13/2002 | EP1178785A1 Compositions and methods for identifying antigens which elicit an immune response |
| 02/13/2002 | EP1019726B1 Prevention of sudden infant death |
| 02/13/2002 | EP0928199B1 Alkaloid glycoside for use as a medicament |
| 02/13/2002 | EP0830142B1 Prrs (porcine reproductive and respiratory syndrome) virus vaccine |
| 02/13/2002 | EP0630257B1 Thymus-derived, immune-enhancing agent for therapeutic use in immunocompromised hosts |
| 02/13/2002 | CN1335889A Chimeric gene encoding the antigenic determinants of four proteins of L.INFANTUM |
| 02/13/2002 | CN1335887A Angiocidin: A Cys-Ser-Val-Thr-Cys-Gly specific tumor cell adhesion receptor |
| 02/13/2002 | CN1335398A Recombinant adenovirus vector capable of being duplicated and spread specifcally inside tumor cell |
| 02/13/2002 | CN1335150A Biogenetic medicine preparing technology with euphorbia |
| 02/12/2002 | US6346608 MecB |
| 02/12/2002 | US6346607 A protein that induces apoptosis or binds cytochrome c; diagnosis and therapy for multiple sclerosis, parkinson's and alzheimer's diseases, cardiovascular diseases, strokes, toxin induced liver disease, cancer, lupus and herpes virus |
| 02/12/2002 | US6346543 Administering baccatin derivative as anticarcinogenic agent |
| 02/12/2002 | US6346517 Synergy between low molecular weight heparin and platelet aggregation inhibitors, providing a combination therapy for the prevention and treatment of various thromboembolic disorders |
| 02/12/2002 | US6346514 Pharmaceutical lysine-containing polypeptide compositions and methods of use thereof |
| 02/12/2002 | US6346422 Method of selecting bacterial strains |
| 02/12/2002 | US6346411 DNA encoding—candida albicans integrin-like protein |
| 02/12/2002 | US6346409 Tryptophenyl tRNA synthetase from Streptococcus pneumoniae |
| 02/12/2002 | US6346396 MurA |
| 02/12/2002 | US6346393 Polynucleotides encoding a ribonuclease s |
| 02/12/2002 | US6346392 Amino acid sequence from streptococcus; drug screening of bactericides and bacteriostats |
| 02/12/2002 | US6346375 NANBV diagnostics and vaccines |
| 02/12/2002 | US6346248 Methods of treating autoimmune diseases with a CD86-specific immunotoxin |
| 02/12/2002 | US6346247 Prevention and treatment of autoimmune disease with luminally administered polyclonal antibodies |
| 02/12/2002 | US6346246 Antibodies that bind human haemopoietic maturation factor |
| 02/12/2002 | US6346242 Compounds and compositions for delivering active agents |
| 02/12/2002 | CA2178915C Maleimide adduct conjugates of procainamide and napa |
| 02/12/2002 | CA2131837C High molecular weight surface proteins of non-typeable haemophilus |
| 02/12/2002 | CA2065847C Rotavirus reassortant vaccine |
| 02/11/2002 | CA2740282A1 Purification of hbv antigens for use in vaccines |
| 02/07/2002 | WO2002010416A1 IMPROVED VIRUS LIKE PARTICLES BASED ON SMALL ENVELOPE PROTEIN FROM HEPATITIS B (HBsAg-S) |
| 02/07/2002 | WO2002010410A1 Compositions for and methods of using herpes simplex virus glycoprotein d to suppress immune responses |
| 02/07/2002 | WO2002010404A2 Regulation of human masp-like serine protease |
| 02/07/2002 | WO2002010403A2 Regulation of human phosphatidylinositol-specific phospholipase c-like enzyme |
| 02/07/2002 | WO2002010402A2 Isolation of drosophila and human polynucleotides encoding par-1 kinase, polypeptides encoded by the polynucleotides and methods utilizing the polynucleotides and polypeptides |
| 02/07/2002 | WO2002010401A2 18431 and 32374, human protein kinase family members and uses therefor |
| 02/07/2002 | WO2002010393A2 Isolated nucleic acid molecules which encode t cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof |
| 02/07/2002 | WO2002010392A2 Mammalian dna binding membrane-associated protein-encoding gene and uses |
| 02/07/2002 | WO2002010388A2 C3b/C4b COMPLEMENT RECEPTOR-LIKE MOLECULES AND USES THEREOF |
| 02/07/2002 | WO2002010387A2 G-protein coupled receptors |
| 02/07/2002 | WO2002010382A2 Trp8, trp9 and trp10, markers for cancer |
| 02/07/2002 | WO2002010379A2 Modified cea and uses thereof |
| 02/07/2002 | WO2002010369A1 Tumor antigen |
| 02/07/2002 | WO2002010363A2 Protein phosphatases |
| 02/07/2002 | WO2002010353A1 Lipo-viro-particle complexes, preparation method and uses |
| 02/07/2002 | WO2002010343A2 Temperature-sensitive live vaccine for mycoplasma hyopneumoniae |
| 02/07/2002 | WO2002010341A1 Microsporidia isolate |
| 02/07/2002 | WO2002010340A1 $i(neospora caninum) isolate |
| 02/07/2002 | WO2002010217A2 Endothelial cell expression patterns |
| 02/07/2002 | WO2002010216A2 Proteins and nucleic acids encoding same |
| 02/07/2002 | WO2002010214A2 Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same |
| 02/07/2002 | WO2002009770A1 Use of rapamycin to inhibit immune response and induce tolerance to gene therapy vector and encoded transgene products |
| 02/07/2002 | WO2002009755A2 Apo-2l receptor agonist and cpt-11 synergism |
| 02/07/2002 | WO2002009754A1 Novel remedies for cancer |
| 02/07/2002 | WO2002009752A2 Immunological adjuvant compounds |
| 02/07/2002 | WO2002009751A2 COMPOSITIONS FOR INDUCING SELF-SPECIFIC ANTI-IgE ANTIBODIES AND USES THEREOF |
| 02/07/2002 | WO2002009750A2 Vaccines for equine herpesvirus type-1: viruses harboring mutations within the immediate early gene |
| 02/07/2002 | WO2002009749A2 Respiratory syncytial virus vaccine |
| 02/07/2002 | WO2002009748A1 Innate immune system-directed vaccines |
| 02/07/2002 | WO2002009747A1 Method for preventing and curing diseases of an immune system and a remedy for carrying out said method |
| 02/07/2002 | WO2002009746A2 Vaccines comprising outer membrane vesciles from gram negative bacteria |
| 02/07/2002 | WO2002009744A2 Modified sialic acid vaccines |
| 02/07/2002 | WO2002009742A1 Method for treating a pancreatic disorder with a neurotoxin |
| 02/07/2002 | WO2002009699A2 Method of treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract |
| 02/07/2002 | WO2002009645A2 Intercellular transport protein linked to an antigen as a molecular vaccine |
| 02/07/2002 | WO2002009643A2 Vaccines for broad spectrum protection against diseases caused by neisseria meningitidis |
| 02/07/2002 | WO2001078773A3 Dissociated pili, their production and use |
| 02/07/2002 | WO2001048205A3 Murine neu sequences and methods of use therefor |
| 02/07/2002 | WO2001042449A3 Methods for introducing genes into mammalian subjects |
| 02/07/2002 | WO2001040240A3 Mono- and disaccharide derivatives |
| 02/07/2002 | WO2001039801A3 Safe attenuated bovine viral diarrhea viruses for use in pregnant cows |
| 02/07/2002 | WO2001034653A3 Protein present at the surface of hematopoietic stem cells of the lymphoid line and of nk cells, and uses thereof |
| 02/07/2002 | WO2001029233A3 Chimeric immunogenic compositions and nucleic acids encoding them |
| 02/07/2002 | WO2001029226A3 Apoptosis inducing proteinaceous substance |
| 02/07/2002 | WO2001002587A3 Novel antifungal agents and fungicides, method for the production thereof and their use |
| 02/07/2002 | US20020016445 Human monoclonal antibodies specific for hepatitis c virus (hcv) e2 antigen |
| 02/07/2002 | US20020016303 Genes which are differentially expressed in cardiovascular disease states, relative to their expression in normal, or non-cardiovascular disease states, and/or in response to manipulations relevant to cardiovascular disease. |
| 02/07/2002 | US20020015737 Proteins deposited onto sparingly soluble biocompatible particles for controlled protein release into a biological environment from a polymer matrix |
| 02/07/2002 | US20020015710 Mimicing the conformational neutralizing epitopes on papilloma virions |